Announced Mon, 7 Sept · 20:52 IST

Parmax Pharma 32nd AGM on Sept 29, 2026 via video conferencing

Board & Shareholder Meetings View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
₹133.75
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0
Up moveDown movePending
AI summary

Parmax Pharma will hold its 32nd AGM on September 29, 2026 at 3:30 PM via video conferencing. Remote e-voting runs September 26 (9 AM) to September 28 (5 PM), with cut-off date September 22. Business includes adoption of FY2025-26 audited financial statements, re-appointment of Umang Gosalia as Director retiring by rotation, and appointment of four directors: Dhiren Chandulal Shah as Non-Executive Chairman and Promoter, Sunil Chinubhai Shah as Non-Executive Director, and Anjana Paresh Shah and Ashish Atmaram Shah as Independent Directors each for 5 years.

Likely market impact

Routine AGM business. Board gets a new Chairman and two Independent Directors, strengthening governance. No dividend or capital action announced.